Quick Answer
Accustem Sciences Inc. reported Stockholders Equity of -$3.31 million for fiscal year 2024.
Accustem Sciences Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$3.31M | -56.9% |
| 2023 | -$2.11M | -1413.1% |
| 2022 | -$139.6K | -121.4% |
| 2021 | $650.7K | -50.3% |
| 2020 | $1.31M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.91M | +8.9% | -14.8% |
| June 30, 2025 | -$2.53M | +12.1% | -17.5% |
| March 31, 2025 | -$2.16M | +17.7% | +34.9% |
| December 31, 2024 | -$3.31M | -56.9% | -3.7% |
| September 30, 2024 | -$3.19M | -69.4% | -10.7% |
| June 30, 2024 | -$2.88M | -120.7% | -10.1% |
| March 31, 2024 | -$2.62M | -176.8% | -24.1% |
| December 31, 2023 | -$2.11M | -1413.1% | -12.0% |
- Accustem Sciences Inc. showed a decrease of -56.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2024 period, Accustem Sciences Inc.’s stockholders equity has declined by 353.0% (from $1.31 million to -$3.31 million).
- The most recent figure is from Accustem Sciences Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: